Randomized Multicentre Comparative Trial to Evaluate the Long Term Effectiveness of the Use of Carbaglu in Patients With Propionic Acidemia (PA) or Methylmalonic Acidemia (MMA)

Trial Profile

Randomized Multicentre Comparative Trial to Evaluate the Long Term Effectiveness of the Use of Carbaglu in Patients With Propionic Acidemia (PA) or Methylmalonic Acidemia (MMA)

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 18 Mar 2017

At a glance

  • Drugs Carglumic acid (Primary)
  • Indications Methylmalonic acidaemia
  • Focus Therapeutic Use
  • Acronyms CAMP
  • Most Recent Events

    • 14 Mar 2017 Planned End Date changed from 1 Mar 2018 to 1 Mar 2019.
    • 14 Mar 2017 Status changed from recruiting to active, no longer recruiting.
    • 16 Nov 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top